Xenazine

Known as: Cambridge Laboratories Brand of Tetrabenazine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
  • XENAZINE XENAZINE
  • 2015
• Increases the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease (5.2… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2014
2014
Chorea is one of the non-thrombotic neurological complications associated with antiphospholipid antibodies (aPL) and it is the… (More)
Is this relevant?
2012
2012
  • Xenazine tetrabenazine
  • 2012
WARNING: DEPRESSION AND SUICIDALITY See full prescribing information for complete boxed warning. Increases the risk of depression… (More)
  • table 1
Is this relevant?
Review
2009
Review
2009
 
Is this relevant?
2008
2008
INTRODUCTION Huntington’s disease (HD) is a progressive autosomal-dominant neuro degenerative disorder caused by 36 or more… (More)
  • table 1
Is this relevant?
2008
2008
  • Each XENAZINE
  • 2008
Depression and Suicidality XENAZINE can increase the risk of depression and suicidal thoughts and behavior (suicidality) in… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2008
2008
  • 2008
NEW DRUGS Rapid-Acting Clevidipine (Cleviprex) for Hypertension The U.S. Food and Drug Administration (FDA) has approved the… (More)
Is this relevant?